Through analyzing GC datasets, we revealed YARS’s co-expression with EGFR amplification, specific mutations, tumor mutation burden, EBV/MSI phenotypes, as well as multiple gene sets potentially those were enriched by YARS high expression. This evidence concerns the gene EGFR and neoplasm.